Skip to search formSkip to main contentSkip to account menu

Lofexidine hydrochloride

Known as: 2-(1-(2,6-Dichlorophenoxy)Ethyl)-2-Imidazoline Monohydrochloride, 1H-Imidazole, 2-(1-(2,6-Dichlorophenoxy)Ethyl)-4,5-Dihydro-, Monohydrochloride, Lofexidine mono-hydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Opioid use disorder (OUD) is a rapidly growing challenge worldwide and is characterized by an increase in dependence on opioids… 
2019
2019
  • M. Choy
  • P & T : a peer-reviewed journal for formulary…
  • 2019
  • Corpus ID: 201836479
Alpelisib (Piqray) for HR-positive/HER2-negative, PIK3CA-mutated, advanced/ metastatic breast cancer; polatuzumab vedotin-piiq… 
2012
2012
Volume 86, Number 6 www.aafp.org/afp American Family Physician 565 Dependence on opioids is a multifactorial condition involving… 
2009
2009
The objective of this study was to characterize the clinical pharmacokinetic profile of lofexidine after oral delivery. A single… 
2009
2009
Objectives: The objective of this study was to investigate lofexidine urine and plasma pharmacokinetics using three different… 
2001
2001
BACKGROUND We hypothesised that the orally-active alpha(2)-adrenoceptor agonist lofexidine hydrochloride would ameliorate chronic… 
1999
1999
Over a period of 24 months, data were collected on 214 opioid detoxifications (190 patients), based on lofexidine hydrochloride… 
Review
1990
Review
1990
  • S. Guthrie
  • DICP : the annals of pharmacotherapy
  • 1990
  • Corpus ID: 23355474
This article discusses current pharmacologic methods in the treatment of heroin dependence and withdrawal. Methadone…